Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy

BACKGROUND: Primary bone cancers are among the deadliest cancer types in adolescents, with osteosarcomas being the most prevalent form. Osteosarcomas are commonly treated with multi-drug neoadjuvant chemotherapy and therapy success as well as patient survival is affected by the presence of tumor sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Robl, Bernhard, Pauli, Chantal, Botter, Sander Martijn, Bode-Lesniewska, Beata, Fuchs, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435808/
https://www.ncbi.nlm.nih.gov/pubmed/25956431
http://dx.doi.org/10.1186/s12885-015-1397-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435808/
https://www.ncbi.nlm.nih.gov/pubmed/25956431
http://dx.doi.org/10.1186/s12885-015-1397-4

Ejemplares similares